Andel is a healthcare technology platform that enables employers to provide affordable access to cash pay medications—starting with GLP-1 therapies—that are increasingly excluded from traditional pharmacy benefit coverage.
As employers continue to reduce coverage for GLP-1s and other brand-name drugs, Andel offers a practical alternative: a structured way to support employee cash purchases on employer-defined terms that are predictable, trackable, and fair.
Why Andel
A differentiated employee benefit
Andel delivers simplified, affordable access to GLP-1 therapies and other brand medicines, helping employers enhance recruitment, productivity, and retention through a highly valued, modern health benefit.
Preferred cash pricing—without administrative burden
Through direct manufacturer relationships, Andel secures preferred cash pricing and delivers it through a turnkey platform, with no employer administrative overhead, no PMPM fees, and no disruption to existing benefits.
Meaningful reduction in total healthcare spend
By expanding access to GLP-1 therapies and other medications, Andel helps reduce downstream medical and pharmacy costs.
Designed to work alongside existing benefits
Andel complements existing PBM and benefits structures, enabling employers to expand access to critical medications without altering their core plans. By making cash purchases of prescription drugs viable at scale, Andel unlocks broad, frictionless access where traditional falls short.
Claimed
